R-(-)-α-methylhistamine, a histamine H3 receptor agonist, induces endothelium-dependent vasodilation in rat mesenteric resistance arteries

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 1, 2010, Pages 58-63

  Sun, Pengyuan ^a   Jin, Xin ^a   Koyama, Toshihiro ^a   Li, Simin ^a   Kitamura, Yoshihisa ^a   Kawasaki, Hiromu ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Endothelium dependent vasodilation; Endothelium derived hyperpolarizing factor; Endothelium derived relaxing factor; Histamine H3 receptor; Rat mesenteric artery

Indexed keywords

ALPHA METHYLHISTAMINE; CHLORPHENIRAMINE; CIMETIDINE; CLOBENPROPIT; HISTAMINE H3 RECEPTOR; INDOMETACIN; METHOXAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; POTASSIUM CHLORIDE; PROSTACYCLIN; TETRYLAMMONIUM; THIOPERAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CELL ACTIVATION; CITRIC ACID CYCLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HYPERPOLARIZATION; MALE; MESENTERIC ARTERY; NONHUMAN; PERFUSION PRESSURE; RAT; RESISTANCE BLOOD VESSEL; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; CARDIOVASCULAR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; HISTAMINE AGONISTS; HISTAMINE ANTAGONISTS; ISOTONIC SOLUTIONS; MALE; MESENTERIC ARTERIES; METHOXAMINE; METHYLHISTAMINES; RATS; RATS, WISTAR; RECEPTORS, HISTAMINE H3; VASODILATION;

EID: 75149135250     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.58     Document Type: Article

References (35)

1. Arrang J. M., Garbarg M., Schwatz J. C., Nature (London), 302, 832-837 (1983).
2. Arrang J. M., Garbarg M., Lancelot J. C., Lecomte J. M., Pollard H., Robba M., Schunack W., Schwartz J. C., Nature (London), 327, 117-123 (1987).
3. Ishikawa S., Sperelakis N., Nature (London), 327, 158-160 (1987).
4. Trzeciakowski J. P., J. Pharmacol. Exp. Ther., 243, 874-880 (1987).
5. Koss M. C., Eur. J. Pharmacol., 257, 109-115 (1994).
6. Valentine A. F., Rizzo C. A., Rivelli M. A., Hey J. A., Eur. J. Pharmacol., 366, 73-78 (1999).
7. Varty L. M., Hey J. A., Eur. J. Pharmacol., 452, 339-345 (2002).
8. Taylor S. J., Kilpatrick G. J., Br. J. Pharmacol., 105, 667-674 (1992).
9. Arrang J. M., Schwatz J. C., Schunack W., Eur. J. Pharmacol., 117, 109-114 (1985).
10. Timmerman H., J. Med. Chem., 33, 4-11 (1990).
11. Van der Goot H., Schepers M. J. P., Sterk G. J., Timmerman H., Eur. J. Med. Chem., 27, 511-517 (1992).
12. Barnes J. C., Brown J. D., Clarke N. P., Clapham J., Evans D. J., O'Shaughnessy C. T., Eur. J. Pharmacol., 250, 147-152 (1993).
13. Breunig E., Michel K., Zeller F., Seidl S., Weyhern C. W., Schemann M., J. Physiol., 583, 731-742 (2007).
14. Hegde S. S., Chan P., Eglen R. M., Eur. J. Pharmacol., 251, 43-51 (1994).
15. Garland C. J., Plane F., Kemp B. K., Trends Pharmacol. Sci., 16, 23-30 (1995).
16. Vanhoutte P. M., Mombouli J. V., Prog. Cardiovasc. Dis., 39, 229-238 (1996).
17. Iwatani Y., Kosugi K., Isobe-Oku S., Atagi S., Kitamura Y., Kawasaki H., Br. J. Pharmacol., 154, 32-40 (2008).
18. Jin X., Satoh-Otonashi Y., Zamami Y., Koyama T., Sun P., Kitamura Y., Kawasaki H., J. Pharmacol. Sci., 108, 95-103 (2008).
19. Ea Kim L., Oudart N., Eur. J. Pharmacol., 150, 393-396 (1988).
20. Ea Kim L., Javelland J., Oudart N., Br. J. Pharmacol., 105, 103-106 (1992).
21. Djuric D. M., Nesic M. T., Andjelkovic I. Z., Mediators Inflamm., 5, 69-74 (1996).
22. Champion H. C., Kadowitz P. J., Am. J. Physiol.: Heart Circ. Physiol., 273, H928-H937 (1997).
23. Champion H. C., Kadowitz P. J., Eur. J. Pharmacol., 343, 209-216 (1998).
24. Kawasaki H., Takasaki K., Saito A., Goto K., Nature (London), 335, 164-167 (1988).
25. Tayo F. M., Bevan J. A., Eur. J. Pharmacol., 121, 129-133 (1986).
26. Jin H., Koyama T., Hatanaka Y., Akiyama S., Takayama F., Kawasaki H., Eur. J. Pharmacol., 529, 136-144 (2006).
27. Furchgott R. F., Zawadaki J. V., Nature (London), 288, 373-376 (1980).
28. Shimokawa H., Yasutake H., Fujii K., Owada M. K., Nakaike R., Fukumoto Y., Takayanagi T., Nagao T., Egashira K., Fujishima M., Takeshita A., J. Cardiovasc. Pharmacol., 28, 703-711 (1996).
29. Chaytor A. T., Evans W. H., Griffith T. M., J. Physiol., 508, 561-573 (1998).
30. Barnes P. J., Ichinose M., Trends Pharmacol. Sci., 10, 264 (1989).
31. Ress S. R., Ratanjee B., Meyers O. L., Keraan M., Br. J. Clin. Pract., 40, 288-291 (1986).
32. Scotland R. S., Chauhan S., Vallance P. J., Ahluwalia A., Hypertension, 38, 833-839 (2001).
33. Zhou M. S., Raij L., J. Hypertens., 21, 1449-1451 (2003).
34. Chen G., Suzuki H., Weston A. H., Br. J. Pharmacol., 95, 1165-1174 (1988).
35. Edwards G., Dora K. A., Gardener M. J., Garland G. J., Weston A. H., Nature (London), 396, 269-272 (1998).